Please assess the completion status of the following clinical trial:

Trial Title: Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A clinical and histologic diagnosis of parapsoriasis (T0 CTCL)~* Age 18 years or older.~* Acceptable laboratory studies~* Must be free of serious concurrent illness.~* Women of child-bearing potential must have negative serum pregnancy test prior to the initiation of treatment.~Exclusion Criteria:~* Topical or systemic therapies within four weeks of entry in the study.~* Participation in any other investigational drug study within thirty days of entry in this study.~* Oral retinoid therapy for any indication within three months of entry in the study.~* Participation in any other study using topical retinoid therapy.~* Pregnancy or active breast-feeding.~* Serious known concurrent medical illness or infection.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).